The executive question
Picture the RA/QA manager in a competitor recall review before an executive update. The CEO is asking whether the team is exposed, but public records alone cannot answer that question.
The first move is not to declare whether the signal raises safety, compliance, reportability, equivalence, or exposure questions. The useful move is to map the public signal to the product family, name missing evidence, and prepare the qualified-review questions.
Competitor recall exposure map
| Map row | What to capture |
|---|---|
| Signal | Recall, alert, adverse-event report, warning letter, or other source. |
| Similarity | Product family, technology, component, supplier, user, setting, and failure-mode notes. |
| Internal evidence | Complaint trend, CAPA screen, risk-file link, supplier file, service record, or label note. |
| Owner | Who validates the evidence and decides the next action. |
| Boundary | What remains open for qualified review. |
What good looks like
The result should separate direct exposure, comparator learning, and monitor-only items. It should give leadership fewer vague opinions and more specific asks: which record is missing, which owner can provide it, and which source should be rechecked.
The map is useful precisely because it does not pretend a public competitor signal can answer a company-specific reportability or safety question by itself.
Source ledger
What it can tell you
Public FDA recall and early-alert records that can trigger competitor or product-family review questions.
What it cannot decide
Whether a competitor event applies to another product, manufacturer, supplier, claim, or complaint file.
What it can tell you
Public adverse-event reports that may help frame signal-review questions and internal evidence requests.
What it cannot decide
Causation, event rate, reportability, exposure, or product defect for a specific device.
What it can tell you
Public enforcement correspondence that can reveal quality-system themes and review topics.
What it cannot decide
Whether another company has the same issue or whether one product has a compliance problem.
Frequently asked questions
Does a competitor recall mean our product is exposed?
No. It creates a review question. Similarity, internal evidence, supplier context, complaints, CAPA, risk, labeling, and qualified judgment determine what the company does next.
What is the first useful output?
A competitor recall exposure map with source links, similarity notes, internal evidence asks, owners, and qualified-review questions.
Need a competitor recall exposure map before the CEO update?
Send the public signal, product family, and executive question. We can scope a source-backed exposure map for qualified review.
Reader feedback
Useful pages should feed the next topic choices. Leave a signal or a short comment.